SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 5/05/22 Illumina, Inc. 10-Q 4/03/22 68:7.4M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 1.07M 2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 27K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 22K 11: R1 Cover Page HTML 73K 12: R2 Condensed Consolidated Balance Sheets HTML 121K 13: R3 Condensed Consolidated Statements of Income HTML 116K 14: R4 Condensed Consolidated Statements of Comprehensive HTML 41K Income 15: R5 Condensed Consolidated Statements of Stockholders? HTML 103K Equity 16: R6 Condensed Consolidated Statements of Cash Flows HTML 120K 17: R7 Organization and Significant Accounting Policies HTML 45K 18: R8 Revenue HTML 59K 19: R9 Investments and Fair Value Measurements HTML 91K 20: R10 Debt HTML 58K 21: R11 Stockholders? Equity HTML 74K 22: R12 Supplemental Balance Sheet Details HTML 58K 23: R13 Legal Proceedings HTML 34K 24: R14 Income Taxes HTML 26K 25: R15 Segment Information HTML 55K 26: R16 Organization and Significant Accounting Policies HTML 44K (Policies) 27: R17 Organization and Significant Accounting Policies HTML 30K (Tables) 28: R18 Revenue (Tables) HTML 53K 29: R19 Investments and Fair Value Measurements (Tables) HTML 85K 30: R20 Debt (Tables) HTML 42K 31: R21 Stockholders? Equity (Tables) HTML 96K 32: R22 Supplemental Balance Sheet Details (Tables) HTML 69K 33: R23 Segment Information (Tables) HTML 50K 34: R24 Organization and Significant Accounting Policies - HTML 44K Narrative - Accounting Pronouncements Adopted in 2022 (Details) 35: R25 Organization and Significant Accounting Policies - HTML 30K Summary of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings Per Share (Details) 36: R26 Revenue - Disaggregation of Revenue (Details) HTML 55K 37: R27 Revenue - Remaining Performance Obligation HTML 38K (Details) 38: R28 Revenue - Narrative (Details) HTML 30K 39: R29 Investments and Fair Value Measurements - HTML 97K Narrative (Details) 40: R30 Investments and Fair Value Measurements - HTML 26K Marketable Equity Securities (Details) 41: R31 Investments and Fair Value Measurements - Fair HTML 60K Value Hierarchy of Assets and Liabilities (Details) 42: R32 Investments and Fair Value Measurements - Changes HTML 36K in Estimated Fair Value of Acquisition Related Contingent Consideration Liabilities (Details) 43: R33 Debt - Summary of Term Debt Obligations (Details) HTML 44K 44: R34 Debt - Narrative (Details) HTML 136K 45: R35 Debt - Summary of Convertible Debt Obligations HTML 40K (Details) 46: R36 Stockholders? Equity - Narrative (Details) HTML 24K 47: R37 Stockholders? Equity - Summary of Restricted Stock HTML 51K Activity and Related Information (Details) 48: R38 Stockholders? Equity - Summary of Stock Option HTML 43K Activity Under all Stock Option Plans (Details) 49: R39 Stockholders? Equity - Narrative - Liability - HTML 33K Classified Award (Details) 50: R40 Stockholders? Equity - Liability - Classified HTML 31K Awards (Details) 51: R41 Stockholders? Equity - Narrative - Employee Stock HTML 29K Purchase Plan (Details) 52: R42 Stockholders? Equity - Narrative - Share HTML 28K Repurchases (Details) 53: R43 Stockholders? Equity - Summary of Share-based HTML 51K Compensation Expense for all Stock Awards (Details) 54: R44 Stockholders? Equity- Summary of Assumptions Used HTML 47K to Estimate the Weighted Average Fair Value Per Share (Details) 55: R45 Supplemental Balance Sheet Details - Schedule of HTML 28K Accounts Receivable (Details) 56: R46 Supplemental Balance Sheet Details - Summary of HTML 33K Inventory (Details) 57: R47 Supplemental Balance Sheet Details - Summary of HTML 36K Accrued Liabilities (Details) 58: R48 Supplemental Balance Sheet Details - Summary of HTML 28K Changes in Reserve for Product Warranties (Details) 59: R49 Supplemental Balance Sheet Details - Narrative - HTML 28K Warranties (Details) 60: R50 Supplemental Balance Sheet Details - Narrative - HTML 29K Derivatives (Details) 61: R51 Legal Proceedings (Details) HTML 33K 62: R52 Income Taxes (Details) HTML 26K 63: R53 Segment Information - Summary of Operating HTML 51K Performance and Assets by Segment (Details) 66: XML IDEA XML File -- Filing Summary XML 120K 64: XML XBRL Instance -- ilmn-20220403_htm XML 1.62M 65: EXCEL IDEA Workbook of Financial Reports XLSX 79K 7: EX-101.CAL XBRL Calculations -- ilmn-20220403_cal XML 167K 8: EX-101.DEF XBRL Definitions -- ilmn-20220403_def XML 612K 9: EX-101.LAB XBRL Labels -- ilmn-20220403_lab XML 1.44M 10: EX-101.PRE XBRL Presentations -- ilmn-20220403_pre XML 876K 6: EX-101.SCH XBRL Schema -- ilmn-20220403 XSD 135K 67: JSON XBRL Instance as JSON Data -- MetaLinks 381± 544K 68: ZIP XBRL Zipped Folder -- 0001110803-22-000021-xbrl Zip 267K
Document |
1 | I have reviewed this Quarterly Report on Form 10-Q of Illumina, Inc.; | ||||||||||
2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | ||||||||||
3 | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | ||||||||||
4 | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | ||||||||||
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||||||||||
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||||||||||
c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | ||||||||||
d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and | ||||||||||
5 | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): | ||||||||||
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | ||||||||||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
By: | /s/ FRANCIS A. DESOUZA | ||||||||||
Francis A. deSouza | |||||||||||
President and Chief Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/5/22 | 4, 8-K | ||
For Period end: | 4/3/22 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/05/23 Illumina, Inc. 10-Q 4/02/23 67:7.1M 2/07/23 Illumina, Inc. 8-K:2,9 2/07/23 11:1.2M 1/11/23 Illumina, Inc. 8-K:2,9 1/09/23 13:332K 12/01/22 Illumina, Inc. 424B2 2:533K Donnelley … Solutions/FA 11/29/22 Illumina, Inc. 424B2 1:500K Donnelley … Solutions/FA 11/04/22 Illumina, Inc. 10-Q 10/02/22 70:8.9M 11/03/22 Illumina, Inc. 8-K:2,9 11/03/22 11:1.1M 8/11/22 Illumina, Inc. 10-Q 7/03/22 72:9M 8/11/22 Illumina, Inc. 8-K:2,9 8/11/22 11:1M |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/18/22 Illumina, Inc. 10-K 1/02/22 108:15M 8/18/21 Illumina, Inc. 8-K:1,2,8,9 8/18/21 12:686K Cravath Swaine & … 01/FA 4/28/21 Illumina, Inc. 10-Q 4/04/21 62:6.5M 1/02/20 Illumina, Inc. 8-K:1,7,9 1/02/20 14:223K 9/26/19 Illumina, Inc. 8-K:1,9 9/25/19 13:218K 11/05/18 Illumina, Inc. 8-K:1,5,8,910/31/18 4:705K |